News
The U.S. Food and Drug Administration has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for ...
Bajaj Holdings & Investment Ltd. key Products/Revenue Segments include Dividend, Income From Sale Of Share & Securities, Interest and Rental Income for the year ending 31-Mar-2024.For the quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback